Biotechnology News

October 24, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA), a leader in the development of RNAi-based therapeutics, today announced that the Company will release its third-quarter 2014 financial results before market open on...

October 24, 2014

DEERFIELD, Ill.--(BUSINESS WIRE)--Lundbeck LLC announced today that it has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application seeking approval of Carbella™ (carbamazepine) injection,...

October 24, 2014

PARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company (NASDAQ:MDCO) will be represented at the American College of Emergency Physicians (ACEP) Annual Scientific Assembly in Chicago, which brings together more than 4,000 emergency medical...

October 24, 2014

IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE: AGN) invites you to listen to David Pyott, Chairman of the Board and Chief Executive Officer, and Jim Hindman, Executive Vice President, Finance and Business Development, Chief Financial...

October 24, 2014

BOULDER, Colo.--(BUSINESS WIRE)--Biodesix Receives NCCN Guidelines Inclusion for VeriStrat. Personalized Medicine for Lung Cancer Patients Moves Forward.

October 24, 2014

SEATTLE--(BUSINESS WIRE)--Governor Jay Inslee joins the Washington Biotechnology & Biomedical Association to celebrate 25 years of life-changing innovation at the Governor's Life Sciences Summit & Annual Meeting.

October 24, 2014

SUNNYVALE, Calif. & NOIDA, India--(BUSINESS WIRE)--HCL Technologies, a leading global IT services company, announced today that it has acquired the status of Life Sciences Competency by Amazon Web Services (AWS). This acknowledgement is part...

October 24, 2014

WILMINGTON, N.C.--(BUSINESS WIRE)--PPD announced it has renewed its commitment as title sponsor of the annual PPD Beach2Battleship Triathlon.

October 24, 2014

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter received U.S. FDA approval for OBIZUR [Antihemophilic Factor (Recombinant), Porcine Sequence] for the treatment of acquired hemophilia A.

October 24, 2014

CAMBRIDGE, Mass. & LAUSANNE, Switzerland--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted its final...

October 24, 2014

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Reports Third Quarter 2014 Financial Results

October 24, 2014

DANBURY, Conn.--(BUSINESS WIRE)--IMS Health Holdings, Inc. (“IMS Health”) (NYSE:IMS), a leading global provider of information and technology services to the healthcare and life sciences industries, today announced results for the quarter ended...

October 24, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, today reported financial results for the three-month period...

October 24, 2014

PLANEGG, Germany--(BUSINESS WIRE)--Biomax releases BioXM Knowledge Management Environment version 5.1 with features to increase productivity, extend underlying semantic concepts, and add responsive web design for use on mobile devices.

October 24, 2014

MUNICH--(BUSINESS WIRE)--Sorin expands manufacturing operations in Germany to increase product capabilities and expand the company industry-leading market share in cardiopulmonary systems

October 24, 2014

OSLO, Norway--(BUSINESS WIRE)--HealthCap VI L.P has pursuant to the subscription agreement entered into on 26 September 2013 between Nordic Nanovector AS (the “Company”), HealthCap VI L.P. and certain shareholders of the Company subscribed for 1,...

October 23, 2014

AUSTIN, Texas--(BUSINESS WIRE)--McKesson Pharmacy Systems and Automation (MPS&A) launched its new SecureHIPAA™ solution this week at the National Community Pharmacists Association’s 116th Annual Convention & Trade Expo

October 23, 2014

BOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology Announces First Patient Enrolled in Lucitanib Phase 2 Study in Squamous Non-small Cell Lung Cancer

October 23, 2014

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, today reported that the U.S. Food and Drug...

October 23, 2014

AUDUBON, Pa.--(BUSINESS WIRE)--Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal implant manufacturer, today announced that it has acquired allograft tissue processor Transplant Technologies of Texas, Ltd. (TTOT). Based in San Antonio...

October 23, 2014

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD to hold conference call and webcast on November 6 at 4:30 pm EST to announce financial results for third quarter ended September 30, 2014.

October 23, 2014

BERKELEY, Calif.--(BUSINESS WIRE)--Aduro BioTech, Inc., a leader in cancer immunotherapy, today announced the presentation of updated safety and efficacy data from an ongoing Phase 1b clinical trial of its novel immunotherapy CRS-207 in...

October 23, 2014

NEW YORK--(BUSINESS WIRE)--The board of directors of Pfizer Inc. today declared a 26-cent fourth-quarter 2014 dividend on the company’s common stock, payable December 2, 2014, to shareholders of record at the close of business on November 7, 2014...

October 23, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--The Board of Directors of PerkinElmer, Inc. (NYSE: PKI), declared a regular quarterly dividend of $0.07 per share of common stock on October 23, 2014. This dividend is payable on February 6, 2015 to all...

October 23, 2014

SAN DIEGO--(BUSINESS WIRE)--La Jolla Pharmaceutical Company Announces Data Presentation at the American Society of Nephrology Kidney Week

October 23, 2014

LYON, France--(BUSINESS WIRE)--Regulatory News: ERYTECH (Paris:ERYP) (Euronext Paris: FR0011471135 - ERYP), the French biopharmaceutical company that develops innovative ‘tumor starvation’ treatments for acute leukemia and other oncology...

October 23, 2014

PITTSBURGH--(BUSINESS WIRE)--RedPath Integrated Pathology, Inc., a leader in molecular diagnostics, announced that results from The National Pancreatic Cyst Registry, a multicenter clinical study, were published online in Endoscopy. The...

October 23, 2014

EVRY, France--(BUSINESS WIRE)--Regulatory News: Global Bioenergies (Paris:ALGBE) (Alternext Paris: ALGBE) announces having reached, and even significantly surpassed, the first productivity objective of the isobutene process defined in the context...

October 23, 2014

WASHINGTON--(BUSINESS WIRE)--AHF to Gilead: Do Your Patriotic Duty and Lower Hep. C Drug Prices for Veterans

October 23, 2014

PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS Revenues for the First 9 Months of 2014 up 16.9%

October 23, 2014

CHICAGO--(BUSINESS WIRE)--Venture capitalists poured $2 billion into health tech in just the first six months of 2014. A passing fad? No, according to a new report by Oliver Wyman: This ongoing investment is the single biggest enabler of a new...

October 23, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron and its partner Celgene will present preclinical and interim clinical data on the sotatercept program at the American Society of Nephrology (ASN) Kidney Week 2014 November 11 - 16, 2014.

October 23, 2014

ARLINGTON, Va.--(BUSINESS WIRE)--Castle Biosciences Inc. today announced that results from a second validation study of its proprietary multi-analyte test, DecisionDx-EC, confirmed the test’s ability to identify which esophageal cancer patients...

October 23, 2014

EAGAN, Minn.--(BUSINESS WIRE)--A clinical trial at the University of Illinois at Chicago will evaluate a new combination therapy for advanced pancreatic cancer that includes two Biothera cancer immunotherapy drug candidates.

October 23, 2014

IRVINE, Calif.--(BUSINESS WIRE)--MusicGlove, World’s First FDA Approved, Clinically Validated Music-Based Hand Rehabilitation Device Proven to Improve a User’s Hand Function after a Stroke or Other Neurological Injuries

October 23, 2014

SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq:XNPT) announced today that it will release its third quarter financial results on November 4, 2014 at approximately 4:30 p.m. Eastern Time. The company will host a conference call at 5:...

October 23, 2014

LONDON--(BUSINESS WIRE)--The Chan Soon-Shiong Institute for Molecular Medicine (CSSIOMM) and the University of Oxford announced a partnership to establish the Chan Soon-Shiong Oxford Center for Molecular Medicine (CSSOCMM), the first of its kind...

October 23, 2014

IRVINE, Calif.--(BUSINESS WIRE)--BIOLASE, Inc. (NASDAQ:BIOL), the world’s leading dental laser manufacturer and distributor, announced today that the Company will host a conference call on Tuesday, November 4th, at 4:30 p.m. Eastern Time to...

October 23, 2014

BRECKSVILLE, Ohio--(BUSINESS WIRE)--MedData, a leading national provider of "patient-focused" revenue cycle management, announces the launch of an iPhone app designed to streamline the medical billing process for its surgical clients.

October 23, 2014

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion announced today that the company will present new data for products in its current portfolio and an investigational compound and device for the treatment of COPD at CHEST 2014.

October 23, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--BIND Therapeutics will report third quarter 2014 financial results on Thursday, November 6, 2014. BIND’s management team will host a conference call and audio webcast at 8:30 a.m. ET.

October 23, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Eleven Biotherapeutics appointed industry veteran Wendy L. Dixon, PhD, former Chief Marketing Officer and President of Global Marketing for Bristol Myers Squibb, to the company’s Board of Directors.

October 23, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, announced today that the US Patent and...

October 23, 2014

CONCORD, Calif.--(BUSINESS WIRE)--The American Red Cross will participate in Cerus’ clinical protocol to make INTERCEPT Platelets available under an Expanded Access IDE to regions with chikungunya and dengue risk.

October 23, 2014

BURLINGAME, Calif.--(BUSINESS WIRE)--Igenica Biotherapeutics, Inc., a company focused on the discovery and development of innovative antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the company will present new...

October 23, 2014

CHICAGO--(BUSINESS WIRE)--Mavens Consulting has received Salesforce’s Partner Innovation Award for marketing innovation.

October 23, 2014

ST. LOUIS--(BUSINESS WIRE)--Certara's enhanced Simcyp solution will enable drug bioequivalence assessment and be able to model additional populations, and diseases, and also consider new mechanisms that impact dermal absorption.